101 related articles for article (PubMed ID: 6098236)
1. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
Cloix JF; Henning G; Crabos M; Delva P; Meyer P
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
[TBL] [Abstract][Full Text] [Related]
2. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
4. [Affinity chromatography for the detection of human endogenous inhibitor of NA+, K+ -ATPase].
Henning G; Cloix JF
C R Seances Acad Sci III; 1983; 297(6):295-8. PubMed ID: 6318931
[TBL] [Abstract][Full Text] [Related]
5. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
[TBL] [Abstract][Full Text] [Related]
6. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
Gentile DA; Skoner DP
Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
[TBL] [Abstract][Full Text] [Related]
7. Similarities and differences between the properties of native and recombinant Na+/K+-ATPases.
Xie Z; Wang Y; Liu G; Zolotarjova N; Periyasamy SM; Askari A
Arch Biochem Biophys; 1996 Jun; 330(1):153-62. PubMed ID: 8651690
[TBL] [Abstract][Full Text] [Related]
8. [Purification of an endogenous inhibitor of sodium-potassium-ATPase].
Cloix JF; Miller ED; Pernollet MG; Devynck MA; Meyer P
C R Seances Acad Sci III; 1983 Feb; 296(5):213-6. PubMed ID: 6303528
[TBL] [Abstract][Full Text] [Related]
9. Functional consequences of substitutions of the carboxyl residue glutamate 779 of the Na,K-ATPase.
Feng J; Lingrel JB
Cell Mol Biol Res; 1995; 41(1):29-37. PubMed ID: 7550450
[TBL] [Abstract][Full Text] [Related]
10. Effects of soybean lipoxygenase on Na+/K+-ATPase activity in vitro.
Kumarathasan R; Leenen FH
Can J Physiol Pharmacol; 2000 Sep; 78(9):691-5. PubMed ID: 11007531
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte membrane ouabain-sensitive Na+, K(+)-ATPase of hypertensive Nigerians.
Olorunsogo OO; Lawal SO; Falase AO; Okunade WG
Afr J Med Med Sci; 1991 Jun; 20(2):75-82. PubMed ID: 1652190
[TBL] [Abstract][Full Text] [Related]
12. Spectrophotometric assay of renal ouabain-resistant Na(+)-ATPase and its regulation by leptin and dietary-induced obesity.
Bełtowski J; Jamroz-Wiśniewska A; Nazar J; Wójcicka G
Acta Biochim Pol; 2004; 51(4):1003-14. PubMed ID: 15625572
[TBL] [Abstract][Full Text] [Related]
13. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
de Wardener H
Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin alters the Na,K-ATPase response to protein kinase C activation in cultured rabbit nonpigmented ciliary epithelium.
Delamere NA; Parkerson J; Hou Y
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):866-75. PubMed ID: 9112982
[TBL] [Abstract][Full Text] [Related]
15. Na-K-ATPase inhibitor dissociated from hypertension-associated plasma protein.
Weiler EW; Khalil-Manesh F; Gonick HC; Prins BA; Purdy RE; Sensharma DK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):364-73. PubMed ID: 10232496
[TBL] [Abstract][Full Text] [Related]
16. Mutant Phe788 --> Leu of the Na+,K+-ATPase is inhibited by micromolar concentrations of potassium and exhibits high Na+-ATPase activity at low sodium concentrations.
Vilsen B
Biochemistry; 1999 Aug; 38(35):11389-400. PubMed ID: 10471289
[TBL] [Abstract][Full Text] [Related]
17. The relation of the natriuretic hormone to essential hypertension.
de Wardener HE; MacGregor GA
Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
[TBL] [Abstract][Full Text] [Related]
18. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
19. [Arguments for the existence of an endogenous inhibitor of renal Na-K ATPase with steroid structure and natriuretic action].
Krzesinski JM; Christiaens L; Palem-Vliers M; Fenghe D; Pequeux-Bar ML; Lomba-Pignon MR; Genard P; Rorive G
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1229-31. PubMed ID: 2175582
[TBL] [Abstract][Full Text] [Related]
20. Thrombin inhibits active sodium-potassium transport in porcine lens.
Okafor MC; Dean WL; Delamere NA
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2033-8. PubMed ID: 10440258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
